Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
Search:

key topics



navigation

Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease that causes chronic joint inflammation and affects more than two million people in the United States. It is reportedly three times more common among women than men. The condition may start at any age but most commonly occurs between the ages of 40 and 60.
Point/Counterpoint: Should You Prescribe Steroids For Rheumatoid Arthritis?
Yes, Dr. Deane says many studies have pointed to the positive results of treating rheumatoid arthritis (RA) with glucocorticoids. No, Dr. Goldman says corticosteroids have a significantly reduced role in the treatment of RA.


A Closer Look At Combination Therapy For RA
Given the debilitating effects of rheumatoid arthritis and recent changes in the evolution of RA treatment, these authors review the literature and discuss the potential impact of combination therapy for this disease.


Emerging Agents For RA: Can They Have An Impact?
Given the recent advances in the understanding of rheumatoid arthritis, these authors offer a closer look at the pathogenesis of the disease and the potential impact of biologic therapies.


Essential Keys To Detecting Early RA
Early detection of rheumatoid arthritis can go a long way toward reducing the risks of joint damage and disability. Accordingly, these authors offer pertinent diagnostic insights to look for in the clinical exam, patient history, lab tests and imaging modalities.


Counseling RA Patients About Lifestyle And Diet Changes
While there have been many advances in the treatment for rheumatoid arthritis (RA), drug therapy is not the only factor that influences the disease. There are several behavioral choices that patients with RA can make that may decrease symptoms of pain and stiffness or signs of joint swelling, and improve their quality of life. Educating patients about these choices and their potential benefits may empower them to make changes that can improve their health and well-being.


What You Should Know About New Antirheumatic Medications
Given the painful and potentially debilitating effects of rheumatoid arthritis, the authors review key diagnostic findings and offer their take on emerging medications.


A Closer Look At Musculoskeletal Ultrasound
Combining a review of the literature with insights from their experience, these rheumatologists offer pertinent pointers about the adjunctive potential of musculoskeletal ultrasound in diagnosing common arthritic conditions ranging from rheumatoid arthritis to crystal-induced arthropathies.


Assessing Older DMARDs And The Roles Of Diet In Treating RA
In this column, our panelists discuss the possible use of older disease-modifying antirheumatic drugs (DMARDs) in managing rheumatoid arthritis (RA), whether nutrition can have an impact in these patients, and the role of magnetic resonance imaging (MRI) in diagnosing RA and monitoring patient progress. Without further delay, here is what our panelists had to say.


Current Concepts In Juvenile Idiopathic Arthritis
Offering a comprehensive review of this condition, this author examines the various subtypes of juvenile idiopathic arthritis, identifies pertinent clinical characteristics and discusses current treatment approaches.


Secrets To Coding For RA And Osteoporosis Drugs
Secrets To Coding For RA And Osteoporosis Drugs Coding Corner: Secrets To Coding For RA And Osteoporosis Drugs - By Antanya A. Chung, CPC and Melesia R. Collins, CPC Rheumatoid arthritis (RA) usually requires a lifelong treatment regimen that may include medications, physical therapy, exercise, education and possibly surgery. Clinicians may prescribe disease-modifying antirheumatic drugs (DMARDs) after less potent drugs prove to be ineffective for a patient. Other DMARDs Clinicians May ...






© 2007 HMP Communications | All Rights Reserved
83 General Warren Blvd | Suite 100 | Malvern, PA 19355
Contact Us | Reprints/Permissions


July 19, 2008

Emerging Concepts In Treating Rheumatoid Arthritis

A complimentary CME Webcast Event

To register for this Web Archive program, click on Complimentary CME Webcast Event


This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine physicians who treat patients with rheumatoid arthritis (RA).


Panelists/Lectures

"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle

"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.

This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


Current Insights On Combination Therapy For Rheumatoid Arthritis

A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)

To register for this Webcast program, click on Complimentary CME Webcast


This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

Agenda And Faculty

“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center

“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center

“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas

This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


A Guide To Viscosupplementation For Osteoarthritis Knee Pain

A complimentary CME Web Archive Event

To register for this Web Archive program, click on Complimentary CME Web Archive Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.

Agenda And Faculty

“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC

“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD

“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY

This activity is supported by an educational grant from Genzyme.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).



A Complimentary CME Webcast Event

A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis

A Complimentary, On-Demand CME Webcast

To register for this Webcast program, click on Complimentary CME Webcast Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

AGENDA and FACULTY

"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology

"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine

"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

This activity is supported by an educational grant from Bristol-Myers Squibb.

The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).